Gypenosides improve diabetic cardiomyopathy by inhibiting <scp>ROS</scp>‐mediated <scp>NLRP</scp>3 inflammasome activationHailong Zhang, Yuanfang Ma|Journal of Cellular and Molecular Medicine|2018Cited by 169